TR200101082T2 - Bilinci veya algılama yeteneğini geliştirici bileşimler. - Google Patents
Bilinci veya algılama yeteneğini geliştirici bileşimler.Info
- Publication number
- TR200101082T2 TR200101082T2 TR2001/01082T TR200101082T TR200101082T2 TR 200101082 T2 TR200101082 T2 TR 200101082T2 TR 2001/01082 T TR2001/01082 T TR 2001/01082T TR 200101082 T TR200101082 T TR 200101082T TR 200101082 T2 TR200101082 T2 TR 200101082T2
- Authority
- TR
- Turkey
- Prior art keywords
- active ingredient
- perception
- alzheimer
- disease
- compositions
- Prior art date
Links
- 230000008447 perception Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 206010012289 Dementia Diseases 0.000 abstract 2
- 230000009286 beneficial effect Effects 0.000 abstract 2
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 230000001627 detrimental effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98203454 | 1998-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200101082T2 true TR200101082T2 (tr) | 2001-09-21 |
Family
ID=8234219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/01082T TR200101082T2 (tr) | 1998-10-16 | 1999-10-12 | Bilinci veya algılama yeteneğini geliştirici bileşimler. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1121131A2 (sk) |
| JP (1) | JP2002527469A (sk) |
| KR (1) | KR20010072878A (sk) |
| CN (1) | CN1367697A (sk) |
| AU (1) | AU6472799A (sk) |
| BG (1) | BG105302A (sk) |
| BR (1) | BR9914419A (sk) |
| CA (1) | CA2345767A1 (sk) |
| EE (1) | EE200100136A (sk) |
| HK (1) | HK1039745A1 (sk) |
| HR (1) | HRP20010262A2 (sk) |
| HU (1) | HUP0103781A3 (sk) |
| ID (1) | ID28441A (sk) |
| IL (1) | IL142588A0 (sk) |
| NO (1) | NO20011403L (sk) |
| PL (1) | PL348107A1 (sk) |
| SK (1) | SK4592001A3 (sk) |
| TR (1) | TR200101082T2 (sk) |
| WO (1) | WO2000023057A2 (sk) |
| ZA (1) | ZA200103081B (sk) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006201188B2 (en) * | 2001-02-05 | 2007-11-15 | Novartis Ag | New use of iloperidone |
| GB0102841D0 (en) * | 2001-02-05 | 2001-03-21 | Novartis Ag | Organic compounds |
| CA2463158C (en) | 2001-10-30 | 2013-07-30 | Novartis Ag | Depot formulations of iloperidone and a star polymer |
| GB0216416D0 (en) | 2002-07-15 | 2002-08-21 | Novartis Ag | Organic compounds |
| WO2004084905A2 (en) * | 2003-03-24 | 2004-10-07 | University Of Florida | Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions |
| TW200501962A (en) * | 2003-04-01 | 2005-01-16 | Novartis Ag | Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| EP1824848A1 (en) * | 2004-12-10 | 2007-08-29 | Abbott Laboratories | Fused bicycloheterocycle substituted quinuclidine derivatives |
| CA2552221A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Donepezil formulations |
| EP2089383B1 (en) | 2006-11-09 | 2015-09-16 | Probiodrug AG | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| MX2007008642A (es) * | 2007-07-16 | 2009-02-25 | World Trade Imp Export Wtie Ag | Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente inhibidor reversible de la enzima colinesterasa, indicada para el control y tratamiento de trastornos psicoticos y demencias. |
| CN102905532A (zh) | 2010-02-09 | 2013-01-30 | 约翰斯.霍普金斯大学 | 用于改善认知功能的方法和组合物 |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| NZ602312A (en) | 2010-03-10 | 2014-02-28 | Probiodrug Ag | Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| JP5945532B2 (ja) | 2010-04-21 | 2016-07-05 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤としてのベンゾイミダゾール誘導体 |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| EP3610890A1 (en) | 2012-11-14 | 2020-02-19 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CN105142623A (zh) | 2013-03-15 | 2015-12-09 | 艾吉因生物股份有限公司 | 用于改善认知功能的方法和组合物 |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| US10159648B2 (en) | 2015-05-22 | 2018-12-25 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
| ES2812698T3 (es) | 2017-09-29 | 2021-03-18 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0584185T3 (da) * | 1991-05-14 | 2000-02-07 | Ernir Snorrason | Behandling af træthedssyndrom med cholinesteraseinhibitorer |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| JP4640888B2 (ja) * | 1997-08-11 | 2011-03-02 | ザ ユニヴァーシティー オブ サウス フロリダ | 神経精神性疾患用ニコチンアンタゴニスト |
| DE69936848T2 (de) * | 1998-04-14 | 2008-05-15 | The General Hospital Corp., Boston | Verwendung von d-serin oder d-alanin zur behandlung von schizophrenie |
-
1999
- 1999-10-12 CA CA002345767A patent/CA2345767A1/en not_active Abandoned
- 1999-10-12 HK HK02100158.6A patent/HK1039745A1/zh unknown
- 1999-10-12 WO PCT/EP1999/007804 patent/WO2000023057A2/en not_active Ceased
- 1999-10-12 EE EEP200100136A patent/EE200100136A/xx unknown
- 1999-10-12 JP JP2000576832A patent/JP2002527469A/ja not_active Withdrawn
- 1999-10-12 HR HR20010262A patent/HRP20010262A2/hr not_active Application Discontinuation
- 1999-10-12 TR TR2001/01082T patent/TR200101082T2/xx unknown
- 1999-10-12 PL PL99348107A patent/PL348107A1/xx unknown
- 1999-10-12 CN CN99812184A patent/CN1367697A/zh active Pending
- 1999-10-12 BR BR9914419-0A patent/BR9914419A/pt not_active IP Right Cessation
- 1999-10-12 SK SK459-2001A patent/SK4592001A3/sk unknown
- 1999-10-12 IL IL14258899A patent/IL142588A0/xx unknown
- 1999-10-12 EP EP99952580A patent/EP1121131A2/en not_active Withdrawn
- 1999-10-12 KR KR1020017002286A patent/KR20010072878A/ko not_active Withdrawn
- 1999-10-12 ID IDW20010828A patent/ID28441A/id unknown
- 1999-10-12 HU HU0103781A patent/HUP0103781A3/hu unknown
- 1999-10-12 AU AU64727/99A patent/AU6472799A/en not_active Abandoned
-
2001
- 2001-03-01 BG BG105302A patent/BG105302A/xx unknown
- 2001-03-20 NO NO20011403A patent/NO20011403L/no not_active Application Discontinuation
- 2001-04-12 ZA ZA200103081A patent/ZA200103081B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9914419A (pt) | 2001-06-26 |
| NO20011403D0 (no) | 2001-03-20 |
| CA2345767A1 (en) | 2000-04-27 |
| SK4592001A3 (en) | 2001-12-03 |
| ID28441A (id) | 2001-05-24 |
| NO20011403L (no) | 2001-03-20 |
| PL348107A1 (en) | 2002-05-06 |
| EP1121131A2 (en) | 2001-08-08 |
| BG105302A (en) | 2001-11-30 |
| KR20010072878A (ko) | 2001-07-31 |
| HUP0103781A2 (hu) | 2002-03-28 |
| WO2000023057A2 (en) | 2000-04-27 |
| WO2000023057A3 (en) | 2000-07-27 |
| AU6472799A (en) | 2000-05-08 |
| JP2002527469A (ja) | 2002-08-27 |
| IL142588A0 (en) | 2002-03-10 |
| HK1039745A1 (zh) | 2002-05-10 |
| ZA200103081B (en) | 2002-07-12 |
| HUP0103781A3 (en) | 2003-09-29 |
| CN1367697A (zh) | 2002-09-04 |
| EE200100136A (et) | 2002-06-17 |
| HRP20010262A2 (en) | 2002-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200101082T2 (tr) | Bilinci veya algılama yeteneğini geliştirici bileşimler. | |
| DE59106756D1 (de) | Neuartige Antiepileptika. | |
| TR200100172T2 (tr) | Oral katı doz formunda eprosartan içeren biyolojik bakımdan kuvvetlendirilmiş formülasyonlar | |
| ES2178036T3 (es) | Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen. | |
| TR200101895T2 (tr) | Cinsel rahatsızlıkların tedavisi. | |
| ES2153975T3 (es) | Derivados de pirimidona con actividad antifungica. | |
| ATE297204T1 (de) | Heilmittel für neurodegenerative krankheiten | |
| MX9701946A (es) | Solucion oftalmica transportadora. | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| ATE147981T1 (de) | Verabreichung von lamotrigin zur behandlung von neuro-aids | |
| MY111260A (en) | Pharmaceutical composition for the treatment of nicotine dependence | |
| ATE228360T1 (de) | Stabilisierte schilddrüsenhormonhaltige arzneimittel | |
| TR199700878T1 (xx) | Monamin oksidaz B inhibit�rleri i�eren farmakotik kompozisyonlar. | |
| TR200200449T2 (tr) | Klonidin içeren etken madde kombinasyonu | |
| SE8103369L (sv) | Antiperspirantkomposition innehallande en aluminiumklorid och en aluminiumzirkoniumhydroxiklorid som aktiva bestandsdelar och sett att inhibera perspiration | |
| NZ319138A (en) | Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi | |
| TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
| DE60132008D1 (de) | Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis | |
| TR199700858A2 (xx) | Alzheimer hastal���n�n tedavisine y�nelik ispen�iyari bile�imler. | |
| YU25001A (sh) | Optički aktivan derivat piridil-4h-1,2,4-oksadiazina i njegova upotreba u proizvodnji lekova za tretiranje vaskularnih bolesti | |
| DK0917460T3 (da) | Cyclosporin-formulering | |
| ATE309803T1 (de) | Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung | |
| DK0593520T3 (da) | Forbindelser med indhold af steroider og deres anvendelse til behandling af glaucom | |
| LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
| FR2710844B1 (fr) | Composition pour le traitement ou la prévention de l'herpès. |